A sensitive bioanalytical method development and validation of cabozantinib in human plasma by LC-ESI-MS/MS. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 54, n. 2, p. e17163, 2018. DOI: 10.1590/s2175-97902018000217163. Disponível em: https://www.revistas.usp.br/bjps/article/view/153781.. Acesso em: 10 may. 2024.